The incidence and significance of anti-natalizumab antibodies

Results from AFFIRM and SENTINEL

PA Calabresi, Egon Stenager

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

OriginalsprogEngelsk
TidsskriftNeurology
Udgave nummer69
Sider (fra-til)1391-1403
ISSN0028-3878
StatusUdgivet - 2007

Citer dette

@article{e21300c0e8f511dc9a76000ea68e967b,
title = "The incidence and significance of anti-natalizumab antibodies: Results from AFFIRM and SENTINEL",
author = "PA Calabresi and Egon Stenager",
year = "2007",
language = "English",
pages = "1391--1403",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams & Wilkins",
number = "69",

}

The incidence and significance of anti-natalizumab antibodies : Results from AFFIRM and SENTINEL. / Calabresi, PA; Stenager, Egon.

I: Neurology, Nr. 69, 2007, s. 1391-1403.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - The incidence and significance of anti-natalizumab antibodies

T2 - Results from AFFIRM and SENTINEL

AU - Calabresi, PA

AU - Stenager, Egon

PY - 2007

Y1 - 2007

M3 - Journal article

SP - 1391

EP - 1403

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 69

ER -